Source:http://linkedlifedata.com/resource/pubmed/id/11943050
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2002-4-10
|
| pubmed:abstractText |
Impact assessment of drug benefits policies is a growing field of research that is increasingly relevant to health care planning for older people. Some cost-containment policies are thought to increase noncompliance. This paper examines mechanisms that can produce spurious reductions in drug utilization measures after drug policy changes when relying on pharmacy dispensing data. Reference pricing, a copayment for expensive medications above a fixed limit, for angiotensin-converting enzyme(ACE) inhibitors in older British Columbia residents, is used as a case example.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0002-8614
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
50
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
521-5
|
| pubmed:dateRevised |
2009-11-3
|
| pubmed:meshHeading |
pubmed-meshheading:11943050-Age Factors,
pubmed-meshheading:11943050-Aged,
pubmed-meshheading:11943050-British Columbia,
pubmed-meshheading:11943050-Drug Prescriptions,
pubmed-meshheading:11943050-Humans,
pubmed-meshheading:11943050-Insurance, Pharmaceutical Services,
pubmed-meshheading:11943050-Longitudinal Studies,
pubmed-meshheading:11943050-Time Factors
|
| pubmed:year |
2002
|
| pubmed:articleTitle |
Prescription duration after drug copay changes in older people: methodological aspects.
|
| pubmed:affiliation |
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Ave., Boston, MA 02115, USA. schneeweiss@post.harvard.edu
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|